BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18508566)

  • 1. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
    Chen Y; Poon RY
    Front Biosci; 2008 May; 13():5016-29. PubMed ID: 18508566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo.
    Niida H; Murata K; Shimada M; Ogawa K; Ohta K; Suzuki K; Fujigaki H; Khaw AK; Banerjee B; Hande MP; Miyamoto T; Miyoshi I; Shirai T; Motoyama N; Delhase M; Appella E; Nakanishi M
    EMBO J; 2010 Oct; 29(20):3558-70. PubMed ID: 20834228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
    J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains.
    Ng CP; Lee HC; Ho CW; Arooz T; Siu WY; Lau A; Poon RY
    J Biol Chem; 2004 Mar; 279(10):8808-19. PubMed ID: 14681223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2.
    Zhang WH; Poh A; Fanous AA; Eastman A
    Cell Cycle; 2008 Jun; 7(11):1668-77. PubMed ID: 18469532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of CHK1 and CHK2 homologues revealed a unique cross talk between ATM and ATR pathways in Neurospora crassa.
    Wakabayashi M; Ishii C; Inoue H; Tanaka S
    DNA Repair (Amst); 2008 Dec; 7(12):1951-61. PubMed ID: 18790091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
    Xiao Z; Xue J; Sowin TJ; Zhang H
    Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.
    Reinhardt HC; Yaffe MB
    Curr Opin Cell Biol; 2009 Apr; 21(2):245-55. PubMed ID: 19230643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chk1 is essential for tumor cell viability following activation of the replication checkpoint.
    Cho SH; Toouli CD; Fujii GH; Crain C; Parry D
    Cell Cycle; 2005 Jan; 4(1):131-9. PubMed ID: 15539958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
    Lee HJ; Hwang HI; Jang YJ
    Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses.
    Martinho RG; Lindsay HD; Flaggs G; DeMaggio AJ; Hoekstra MF; Carr AM; Bentley NJ
    EMBO J; 1998 Dec; 17(24):7239-49. PubMed ID: 9857181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.
    Ho CC; Siu WY; Lau A; Chan WM; Arooz T; Poon RY
    Cancer Res; 2006 Feb; 66(4):2233-41. PubMed ID: 16489026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage checkpoint kinases in cancer.
    Smith HL; Southgate H; Tweddle DA; Curtin NJ
    Expert Rev Mol Med; 2020 Jun; 22():e2. PubMed ID: 32508294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint.
    Ho CC; Siu WY; Chow JP; Lau A; Arooz T; Tong HY; Ng IO; Poon RY
    Exp Cell Res; 2005 Mar; 304(1):1-15. PubMed ID: 15707569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.
    Adamson AW; Beardsley DI; Kim WJ; Gao Y; Baskaran R; Brown KD
    Mol Biol Cell; 2005 Mar; 16(3):1513-26. PubMed ID: 15647386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.